Kestra Medical Technologies, Ltd. (KMTS) Q4 2026 Earnings Call Transcript
Kestra Medical Technologies, Ltd. (KMTS) Q4 2026 Earnings Call Transcript
Seeking Alpha7/14/2026Neutral
KMTS
Kestra Medical Technologies, Ltd. Common StockNASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$1.40B
P/E Ratio
—
EPS
$-2.54
Beta
—
52W High
$30.00
52W Low
$14.10
50-Day MA
$22.29
200-Day MA
$23.52
Dividend Yield
—
Profit Margin
-138.30%
Forward P/E
—
PEG Ratio
—
About Kestra Medical Technologies, Ltd. Common Stock
Kestra Medical Technologies, Ltd. is a wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington.
Fundamentals
| Revenue (TTM) | $95.13M |
| Gross Profit (TTM) | $48.86M |
| EBITDA | $-126.03M |
| Operating Margin | -137.40% |
| Return on Equity | -56.60% |
| Return on Assets | -25.80% |
| Revenue/Share (TTM) | $1.76 |
| Book Value | $4.45 |
| Price-to-Book | 5.15 |
| Price-to-Sales (TTM) | 14.70 |
| EV/Revenue | 12.49 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 66.20% |
| Shares Outstanding | $58.60M |
| Float | $32.63M |
| % Insiders | 5.91% |
| % Institutions | 102.58% |
Historical Volatility
HV 10-Day
74.17%
HV 20-Day
60.32%
HV 30-Day
75.59%
HV 60-Day
70.14%
HV Rank
85.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($30.00 target)
1
Strong Buy5
Buy1
HoldLatest News
Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing
KIRKLAND, Wash., July 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced that it has entered into a five-year term loan facility with funds managed by Pharmakon Advisors, LP.
GlobeNewsWire7/14/2026Neutral
Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Results
KIRKLAND, Wash., July 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results for the fourth quarter and fiscal year ended April 30, 2026.
GlobeNewsWire7/14/2026Neutral
Kestra Medical Technologies to Report Fourth Quarter Fiscal 2026 Financial Results on July 14
KIRKLAND, Wash., June 30, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, is scheduled to report fourth quarter fiscal 2026 financial results after the market closes on Tuesday, July 14.
GlobeNewsWire6/30/2026Neutral
Kestra Medical Technologies to Present at the BofA Securities 2026 Healthcare Conference
KIRKLAND, Wash., April 29, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd.
GlobeNewsWire4/29/2026Neutral
Kestra Showcases Accelerated Innovation at HRS 2026
KIRKLAND, Wash., April 22, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd.
GlobeNewsWire4/22/2026Neutral
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on KMTS and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 7/29/2026